Botanix Pharmaceuticals Limited (ASX:BOT)
Australia
· Delayed Price · Currency is AUD 0.4300
+0.0100 (2.38%)
Apr 28, 2025, 10:02 AM AEST
Botanix Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
| Cash & Equivalents | 48.44 | 79.31 | 10.25 | 7.29 | 21.55 | 24.65 | Upgrade
|
| Cash & Short-Term Investments | 48.44 | 79.31 | 10.25 | 7.29 | 21.55 | 24.65 | Upgrade
|
| Cash Growth | 164.49% | 673.71% | 40.69% | -66.20% | -12.54% | 423.87% | Upgrade
|
| Accounts Receivable | 0.8 | 0.46 | 0.4 | - | - | - | Upgrade
|
| Other Receivables | - | 0.36 | 0.09 | 0.14 | 0.05 | 0.13 | Upgrade
|
| Receivables | 0.8 | 0.82 | 0.49 | 0.14 | 0.05 | 0.13 | Upgrade
|
| Inventory | 17.08 | 1.21 | 3.15 | 3.04 | - | - | Upgrade
|
| Prepaid Expenses | 1.48 | 0.1 | 0.09 | 0.03 | 0.01 | 0 | Upgrade
|
| Other Current Assets | - | 1.47 | - | - | - | - | Upgrade
|
| Total Current Assets | 67.79 | 82.9 | 13.98 | 10.5 | 21.61 | 24.78 | Upgrade
|
| Property, Plant & Equipment | 0.93 | 0.07 | 0.07 | 0.18 | 0.28 | 0.45 | Upgrade
|
| Other Intangible Assets | 30.73 | 29.49 | 6.86 | 3.3 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | 3.87 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | 0.06 | 0.06 | 0.06 | 0.09 | Upgrade
|
| Total Assets | 99.45 | 112.46 | 24.84 | 14.04 | 21.95 | 25.31 | Upgrade
|
| Accounts Payable | 4.16 | 2.73 | 1.39 | 4.68 | 0.65 | 1.01 | Upgrade
|
| Accrued Expenses | 1.32 | 0.56 | 0.15 | 0.1 | 0.09 | 0.08 | Upgrade
|
| Current Portion of Leases | 0.28 | - | - | 0.12 | 0.15 | 0.12 | Upgrade
|
| Other Current Liabilities | 0.61 | 0.44 | 0.34 | 0.99 | 0.15 | 0.17 | Upgrade
|
| Total Current Liabilities | 6.38 | 3.73 | 1.88 | 5.89 | 1.04 | 1.38 | Upgrade
|
| Long-Term Leases | 0.58 | - | - | - | 0.11 | 0.3 | Upgrade
|
| Total Liabilities | 6.96 | 3.73 | 1.88 | 5.89 | 1.15 | 1.67 | Upgrade
|
| Common Stock | 188.84 | 188.32 | 93.49 | 71.48 | 71.48 | 71.41 | Upgrade
|
| Retained Earnings | -121.68 | -90.79 | -76.92 | -67.77 | -54.6 | -51.26 | Upgrade
|
| Comprehensive Income & Other | 25.33 | 11.2 | 6.38 | 4.44 | 3.92 | 3.49 | Upgrade
|
| Shareholders' Equity | 92.49 | 108.73 | 22.95 | 8.15 | 20.8 | 23.64 | Upgrade
|
| Total Liabilities & Equity | 99.45 | 112.46 | 24.84 | 14.04 | 21.95 | 25.31 | Upgrade
|
| Total Debt | 0.87 | - | - | 0.12 | 0.26 | 0.42 | Upgrade
|
| Net Cash (Debt) | 47.57 | 79.31 | 10.25 | 7.16 | 21.3 | 24.22 | Upgrade
|
| Net Cash Growth | 159.76% | 673.71% | 43.10% | -66.36% | -12.09% | 414.93% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.05 | 0.01 | 0.01 | 0.02 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 1,818 | 1,814 | 1,421 | 1,085 | 973.14 | 972.7 | Upgrade
|
| Total Common Shares Outstanding | 1,818 | 1,810 | 1,312 | 973.14 | 973.14 | 972.7 | Upgrade
|
| Working Capital | 61.42 | 79.17 | 12.09 | 4.62 | 20.57 | 23.4 | Upgrade
|
| Book Value Per Share | 0.05 | 0.06 | 0.02 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Tangible Book Value | 61.76 | 79.24 | 16.1 | 4.86 | 20.8 | 23.64 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.04 | 0.01 | 0.00 | 0.02 | 0.02 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.